Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Evogene
EVGNCurrent price
1.38 USD
-0.04 USD (-2.82%)
Last closed
1.43 USD
Company
www.evogene.com
ISIN
IL0011050551
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
8 966 430 USD
Yield for 12 month
-82.51 %
1Y
3Y
5Y
10Y
15Y
EVGN
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in life-science based industries, including human health, agriculture, and other industrial applications through the use of its Computational Predictive Biology (CPB) platform. The company operates through three segments: Agriculture, Human Health, and Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, gastrointestinal inflammatory related disorders, and antimicrobial resistance organisms. The Industrial Applications segment develops enhanced castor bean seeds to serve as a feedstock source for other industrial uses. The company also provides medical cannabis products. It operates in the United States, Israel, Brazil, and internationally. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel. Address: 13 Gad Feinstein Street, Rehovot, Israel, 7638517
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
8.13 USDP/E ratio
–Dividend Yield
–Current Year
+5 640 000 USD
Last Year
+1 675 000 USD
Current Quarter
+1 796 000 USD
Last Quarter
+914 000 USD
Current Year
+1 399 000 USD
Last Year
+766 000 USD
Current Quarter
+715 000 USD
Last Quarter
-236 000 USD
Key Figures EVGN
1 year
3 years
5 years
10 years
EBITDA
-19 672 000 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-28.46 %
PEG Ratio
–
Return On Equity TTM
-82.37 %
Wall Street Target Price
8.13 USD
Revenue TTM
9 449 000 USD
Book Value
2.38 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
39.80 %
Dividend Yield
–
Gross Profit TTM
766 000 USD
Earnings per share
-4.46 USD
Diluted Eps TTM
-4.46 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-210.26 %
Dividend Analytics EVGN
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History EVGN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
1:10
Payout Ratio
–
Last Split Date
25.07.2024
Stock Valuation EVGN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
0.49
Price Sales TTM
0.95
Enterprise Value EBITDA
-0.81
Price Book MRQ
4.71
Financials EVGN
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators EVGN
For 52 weeks
1.22 USD
10.40 USD
50 Day MA
2.02 USD
Shares Short Prior Month
135 057
200 Day MA
4.97 USD
Short Ratio
0.040
Shares Short
81 969
Short Percent
0.42 %
BeatStart